Seval Akpınar profile image
Seval Akpınar Assoc. Prof. Dr. NAMIK KEMAL ÜNİVERSİTESİ
Publication 2 Review 0
2 Publication
0 Review

Research Fields

Haematology

Institution

NAMIK KEMAL ÜNİVERSİTESİ

Publications

Brentuximab Vedotin Monotherapy in Relapsed/Refractory T Cell Lymphoma Setting-Real Life Data
Authors: Tahir Darcın , Istemi Serın , Mehmet Can Ugur , Omer Ekinci , İpek Yönal Hindilerden , Seval Akpınar , Tuba Hacıbekiroglu , Sinan Demircioğlu , Emine Gulturk , Murat Albayrak , İsmet Aydoğdu , Mehmet Sinan Dal , Mehmet Hilmi Doğu , Sinem Namdaroğlu , Ali Dogan , Meliha Nalçacı , Burhan Turgut , Semih Başcı , Fevzi Altuntaş
Published: 2024 , Hitit Medical Journal
DOI: 10.52827/hititmedj.1320606
FAVORITE 0 TOTAL DOWNLOAD COUNT 161

0

161

KORONAVİRÜS HASTALIĞI (COVID-19) İLE İLİŞKİLİ KOAGÜLOPATİ
Authors: Seval Akpınar
Published: 2020 , Namık Kemal Tıp Dergisi
DOI: 10.37696/nkmj.772162
FAVORITE 0 TOTAL DOWNLOAD COUNT 1347

0

1347

Articles published in
Hitit Medical Journal
Hitit Medical Journal
Namık Kemal Tıp Dergisi
Namık Kemal Tıp Dergisi
User doesn't have any peer review duties on DergiPark.
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.